ID
33355
Beskrivning
Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01206881
Länk
https://clinicaltrials.gov/show/NCT01206881
Nyckelord
Versioner (1)
- 2018-12-06 2018-12-06 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
6 december 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Cancer NCT01206881
Eligibility Breast Cancer NCT01206881
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
Cancer Other
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1707251
Beskrivning
Investigational New Drugs
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0013230
Beskrivning
Disease Study Subject Participation Status Contraindicated | Condition Study Subject Participation Status Contraindicated
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C2348568
- UMLS CUI [1,3]
- C1444657
- UMLS CUI [2,1]
- C0348080
- UMLS CUI [2,2]
- C2348568
- UMLS CUI [2,3]
- C1444657
Beskrivning
Pregnancy | Breast Feeding
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Breast Cancer NCT01206881
- StudyEvent: Eligibility
C0333348 (UMLS CUI [1,2])
C0027651 (UMLS CUI [2,1])
C0456389 (UMLS CUI [2,2])
C0521317 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C2348568 (UMLS CUI [1,2])
C1444657 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C1444657 (UMLS CUI [2,3])
C0006147 (UMLS CUI [2])